Therapy Areas
29 October 2020 - - US-based pharmaceutical company Moleculin Biotech, Inc., (NASDAQ: MBRX) has entered into an agreement with the University of Campinas in São Paulo, Brazil to further enable collaboration into its research on the a...
29 October 2020 - - The New England Journal of Medicine has published data from the monotherapy arms of BLAZE-1, a Phase 2 study assessing the efficacy and safety of US-based pharmaceutical company Eli Lilly and company's (NYSE: LLY) b...
29 October 2020 - - The first patient has been dosed at the Emory University School of Medicine in Atlanta, Georgia as part of the in the ACTIV-5 "Big Effect Trial" (ACTIV-5/BET) evaluating lenzilumab with remdesivir, compared to placebo an...
29 October 2020 - - A COVID-19 immune response study has revealed new findings that suggest that treatments aimed at arresting the infection at the stage of moderate severity may be most effective, the US-based non-profit biomedical research organisa...
29 October 2020 - - US-based biotechnology company Qualigen Therapeutics, Inc. (NASDAQ: QLGN) has received written feedback to its Type B Pre-IND (Pre-Investigational New Drug application) meeting request from the US Food and Drug Administration...
29 October 2020 - - German drugmaker Boehringer Ingelheim has initiated a Phase 2 clinical trial of BI 764198, an inhibitor of TRPC6, a receptor-operated cation channel, the company said.

This potent and selective inhibitor of TRPC6 may ...
29 October 2020 - - US-based biotechnology company Moderna, Inc. (NASDAQ: MRNA) has confirmed that the Ministry of Health, Labour and Welfare of Japan and Japanese drugmaker Takeda Pharmaceutical Co., Ltd (NYSE: TAK) have agreed to purchase and ...